Document and Entity Information
Document and Entity Information | May 07, 2020 |
Cover [Abstract] | |
Document Type | 8-K/A |
Document Period End Date | May 7, 2020 |
Entity Registrant Name | Zymeworks Inc. |
Entity Incorporation, State or Country Code | A1 |
Entity File Number | 001-38068 |
Entity Tax Identification Number | 98-1398788 |
Entity Address, Address Line One | Suite 540, 1385 West 8th Avenue |
Entity Address, City or Town | Vancouver |
Entity Address, State or Province | BC |
Entity Address, Country | CA |
Entity Address, Postal Zip Code | V6H 3V9 |
City Area Code | 604 |
Local Phone Number | 678-1388 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Shares, no par value per share |
Trading Symbol | ZYME |
Security Exchange Name | NYSE |
Entity Emerging Growth Company | false |
Amendment Description | This current report on Form 8-K/A (this “Amendment”) updates information originally provided under Item 5.07 in a Current Report on Form 8-K filed on May 8, 2020 (the “Original Filing”), in which Zymeworks Inc. (the “Company”) reported voting results for its 2020 annual meeting of shareholders held on May 7, 2020 (the “2020 Annual Meeting”), including the results of the advisory and non-binding vote regarding the frequency of future advisory and non-binding votes on compensation of the Company’s named executive officers. The sole purpose of this Amendment is to update the Original Filing in accordance with Item 5.07(d) of Form 8-K to disclose the Company’s decision regarding how frequently it will conduct future shareholder advisory votes to approve the compensation of the Company’s named executive officers and, except as set forth below, this Amendment does not modify or update any other disclosure contained in the Original Filing, and this Amendment should be read in conjunction with the Original Filing. |
Amendment Flag | true |
Entity Central Index Key | 0001403752 |